Non-metastatic Prostate Cancer

Oncology·MeSH: Prostatic Neoplasms

Prevalence

256.0 / 100K

Incidence

111.0 / 100K/yr

0 drugs in development·0 companies·3 clinical trials

Frequently asked questions

How many clinical trials target Non-metastatic Prostate Cancer?

There are 3 clinical trials targeting Non-metastatic Prostate Cancer tracked by BioSniper.

What is the prevalence of Non-metastatic Prostate Cancer?

The estimated prevalence of Non-metastatic Prostate Cancer is approximately 256.0 per 100,000 population.

Deep-dive into Non-metastatic Prostate Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Non-metastatic Prostate Cancer — Drugs in Development & Clinical Trials | BioSniper